Abstract
This international symposium was hold in Cádiz in November 2002. In the first conference, a classification of anticancer drugs including all the new compounds was proposed. The role of cholino-kinase in oncogenesis was revised, as well as the possibility to use this model in the development of new drugs. The first group of conferences was finished with a speech about how we are investigating with new drugs, considering the limitations of our traditional paradigm. The second group of conferences included a revision of different drugs: monoclonal antibodies, gefitinib, imatinib and Cox-2 inhibitors. The speakers commented on the results of clinical trials and the future investigation with these drugs. Finally, the third block included a revision a techniques in molecular oncology and a speech about the kind of information that we are achieving through the use of these techniques.
| Translated title of the contribution | 10th International course in progress in Oncology: Research and new drugs |
|---|---|
| Original language | Spanish |
| Pages (from-to) | 98-110 |
| Number of pages | 13 |
| Journal | Clinical and Translational Oncology |
| Volume | 5 |
| Issue number | 2 |
| State | Published - Mar 2003 |
| Externally published | Yes |
Keywords
- Cholino-kinase
- Gefitinib
- Monoclonal imatinib
ASJC Scopus subject areas
- Oncology
- Cancer Research